BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4036090)

  • 1. [2,3-diphosphoglycerate level during the active and maintenance treatment of iron-deficiency anemia patients].
    Iordanova E; Dosheva I; Lulcheva F; Tsvetkova N; Dobrev K
    Vutr Boles; 1985; 24(2):78-82. PubMed ID: 4036090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferritin versus ferrous sulphate preparations: a controlled study in sideropaenic patients.
    Sás G; Scheffer K; Schreiber G; Bräuer H; Ceccarelli G
    Pharmatherapeutica; 1986; 4(10):673-8. PubMed ID: 3299394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment and prevention of iron deficiency anemia].
    Miterev IuG; Voronina LN
    Klin Med (Mosk); 1989 Aug; 67(8):109-14. PubMed ID: 2811230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reticulocyte indices rapidly reflect an increase in iron availability for erythropoiesis.
    Kotisaari S; Romppanen J; Agren U; Eskelinen S; Punnonen K
    Haematologica; 2003 Dec; 88(12):1422-3. PubMed ID: 14687997
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tardyferon-depot in the treatment of iron deficiency anemia].
    Hołowiecki J; Stella-Hołowiecka B; Harbut-Gryłka A
    Acta Haematol Pol; 1976 OCT-DEC; 7(4):321-5. PubMed ID: 998142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gestational iron deficiency disease with tardyferon; monitoring the effectivity of treatment.
    Pejtsik B; Pácsa S; Pereszlényi L
    Ther Hung; 1988; 36(1):25-8. PubMed ID: 3388288
    [No Abstract]   [Full Text] [Related]  

  • 7. [The morphofunctional characteristics of the adaptation of the erythron system in patients with iron-deficiency anemia].
    Ovchar TT
    Lik Sprava; 1992 Aug; (8):45-8. PubMed ID: 1475925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron deficiency anemia and catecholamine metabolism.
    Patiroglu T; Dogan P
    Indian Pediatr; 1991 Jan; 28(1):51-6. PubMed ID: 2055611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of iron deficiency anemia and the prevention of its recurrences using Soviet iron-containing preparations].
    Abdulkadyrov KM; Beliakova TA; Andrianova IG
    Klin Med (Mosk); 1980 Apr; 58(4):61-7. PubMed ID: 7382370
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1,000 patients.
    Liguori L
    Int J Clin Pharmacol Ther Toxicol; 1993 Mar; 31(3):103-23. PubMed ID: 8468108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anemia 2,3-DPG and tissue oxygenation in beta-thalassemia heterozygotes].
    Tassiopoulos T; Kaltsoya-Tassiopoulos A; Alchanati N; Rombos J; Pournaras N; Fessas P
    Nouv Rev Fr Hematol (1978); 1982; 24(6):359-62. PubMed ID: 7167385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience in the treatment of iron deficiency anemia with ferro-folgamma].
    Nikitin EN; Krasnoperova OV; Nikitin IuE
    Klin Med (Mosk); 2009; 87(3):64-7. PubMed ID: 19469261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of ferrous sulfate and ferrous glycinate chelate for the treatment of iron deficiency anemia in gastrectomized patients.
    Mimura EC; Breganó JW; Dichi JB; Gregório EP; Dichi I
    Nutrition; 2008; 24(7-8):663-8. PubMed ID: 18499399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of iron deficiency with orally administered delayed-action ferrous sulfate and mucoproteose].
    Schindler VH; Bielesz G
    Wien Med Wochenschr; 1975 Mar; 125(11):173-6. PubMed ID: 1130090
    [No Abstract]   [Full Text] [Related]  

  • 16. Intraerythrocytic adaptation to anaemia in thalassaemia.
    Alvarez-Sala JL; Villegas A; Alarcón C; Espinós D
    Nouv Rev Fr Hematol (1978); 1983; 25(4):267-8. PubMed ID: 6622252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iron deficiency and sickle cell anemia.
    Rao KR; Patel AR; Honig GR; Vida LN; McGinnis PR
    Arch Intern Med; 1983 May; 143(5):1030-2. PubMed ID: 6679216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased erythrocytic diphosphoglycerate in megaloblastic anaemia. A compensatory mechanism?
    Fernandes-Costa FJ; Green R; Torrance JD
    S Afr Med J; 1978 May; 53(18):709-12. PubMed ID: 694604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Iron deficiency anemia and conditions (diagnosis, treatment and prevention].
    Miterev IuG; Voronina LN
    Klin Med (Mosk); 1992; 70(7-8):69-77. PubMed ID: 1460835
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in iron status during competitive season in female collegiate swimmers.
    Brigham DE; Beard JL; Krimmel RS; Kenney WL
    Nutrition; 1993; 9(5):418-22. PubMed ID: 8286880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.